Trump's New Deal: Lower Prices for Obesity Drugs

Former President Donald Trump announces a deal with Eli Lilly and Novo Nordisk to lower prices of obesity drugs Zepbound and Wegovy, potentially reducing costs by up to 85% and expanding coverage for Medicare patients. This move is part of the Trump administrations efforts to address rising drug prices and cost-of-living concerns. The Daily News Now! - Every city. Every story. AI Powered. Hosted on Acast. See acast.com/privacy for more information.